Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol

Keyphrases

• MK-801 100%
• Clozapine 100%
• Latent Inhibition 100%
• Systemic Administration 100%
• Haloperidol 100%
• Pre-exposure 15%
• Perseveration 15%
• Schizophrenia 10%
• Negative Symptoms of Schizophrenia 10%
• NMDA Antagonist 10%
• Mechanism of Action 5%
• Attentional Set-shifting 5%
• Screening Tool 5%
• N-methyl-D-aspartate Receptor (NMDAR) 5%
• Footshock 5%
• Symptomatology 5%
• Schizophrenic Patients 5%
• Antipsychotics 5%
• Drug-induced 5%
• Behavioral Effects 5%
• NMDA Receptor Blockade 5%
• Response Procedures 5%
• Typical Neuroleptics 5%
• Atypical Neuroleptics 5%
• Inhibition Model 5%
• Antipsychotic Activity 5%
• Other-report 5%
• Attentional Deficits 5%
• Perseverative Behavior 5%
• Induced Models 5%
• Conditioned Inhibition 5%
• Conditioned Emotional Response 5%
• Novel Antipsychotics 5%
• Non-competitive 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Clozapine 100%
• Systemic Administration 100%
• 4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol 100%
• Antipsychotic 60%
• Negative Syndrome 40%
• N Methyl Dextro Aspartic Acid Receptor Blocking Agent 40%
• N Methyl Dextro Aspartic Acid Receptor 40%
• Symptomatology 20%
• Typical Antipsychotic 20%
• Behavioral Effect 20%
• Atypical Antipsychotics 20%

Neuroscience

• Latent Inhibition 100%
• Clozapine 100%
• Haloperidol 100%
• Dementia Praecox 21%
• Negative Syndrome 10%
• NMDA Receptor 10%
• NMDA Receptor Antagonist 10%
• Antipsychotic 10%
• Typical Antipsychotic 10%
• Behavior (Neuroscience) 5%
• Behavioral Effect 5%